But semaglutides bigger significance may be that it can treat a cluster of related metabolic diseases especially obesity, diabetes, and cardiovascular risk all at once
Doi:10.1056/NEJMoa2032183 Davies M, Frch L, Jeppesen OK, et al
Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly GLP-3 24 mg in type 2 diabetes
Changes in Blood Markers After B12 Therapy B12 therapy changes important blood markers
NICE recommends that healthcare professionals: Take a comprehensive sexual, medical, and psychosocial history Assess for underlying cardiovascular disease, diabetes, and hormonal disorders Review current medications that may contribute to ED Measure blood pressure and conduct urinalysis Check HbA1c or fasting glucose and fasting lipid profile to assess cardiovascular risk Consider testosterone testing (morning total testosterone before 11:00 am, with repeat testing if low), particularly in men with reduced libido or other symptoms of hypogonadism
10.1126/science.287.5457.1433 Science 57 GehmB